Individual

For people managing their own savings and investments.

Financial advisors and wealth managers

For people managing savings and/or investments on behalf of someone else.

Institutional

For pension schemes, insurers, charities, universities, family offices and treasurers.

Change country site
  1. Homepage
  2. Insights & Research
In a landmark announcement, President Donald Trump revealed that Oracle, OpenAI, and Softbank are joining forces to build data centers across the US, a move set to power the ambitious Stargate project.[1]

This $500 billion initiative aims to create a robust artificial intelligence (AI) infrastructure that will advance AI and fuel the development of a cancer vaccine. This collaboration marks a significant milestone in the intersection of technology and healthcare, promising transformative impacts on healthcare investing in 2025.

A brief overview

The Stargate project

The Stargate project is a massive undertaking designed to establish a comprehensive AI infrastructure in the US. With an initial investment of $100 billion, it is expected to expand to $500 billion over the next four years.2 The primary goal is to build state-of-the-art data centers that will support developing and deploying advanced AI technologies. These data centers will be strategically located across various states, initially breaking ground in Texas.3

The collaboration between Oracle, OpenAI, and Softbank brings together some of the tech industry's most influential players.

The collaboration between Oracle, OpenAI, and Softbank brings together some of the tech industry's most influential players. Oracle, known for its database management and cloud computing expertise, will provide the necessary infrastructure and technological support. OpenAI, a leader in AI research, will leverage its cutting-edge AI models and algorithms.4 Softbank, with its vast financial resources and investment acumen, will ensure the project's scalability and sustainability.5

Advancing cancer research with AI

One of the most exciting aspects of the Stargate project is its potential to revolutionize cancer research and treatment. Larry Ellison, Oracle's founder, highlighted how the project will enable early cancer detection and the development of personalized cancer vaccines.6 By utilizing AI to analyze blood tests, researchers can identify cancer markers at an early stage, significantly improving the chances of successful treatment.

The integration of AI in cancer research could lead to unprecedented advancements in early detection, treatment, and, potentially, the eradication of certain types of cancer.

Moreover, AI can be used to sequence cancer tumors and design customized mRNA vaccines tailored to individual patients. This approach promises to create vaccines within 48 hours, offering a rapid and personalized treatment option.4 The integration of AI in cancer research could lead to unprecedented advancements in early detection, treatment, and, potentially, the eradication of certain types of cancer.

Implications for healthcare investing

The Stargate project is poised to have a profound impact on healthcare investing in 2025. The healthcare sector, which has faced challenges and underperformance in recent years, is expected to benefit significantly from this AI-driven initiative.5 Here are some key implications for investors:

Increased investment in AI and healthcare technologies

The Stargate project will likely attract substantial investment in AI and healthcare technologies. Companies involved in AI research, data analytics, and biotechnology are expected to see increased funding and growth opportunities. Investors looking to capitalize on these trends should consider allocating resources to these sectors.

Boost in healthcare stocks

The integration of AI in healthcare is anticipated to drive innovation and efficiency, leading to improved patient outcomes and cost savings. As a result, healthcare stocks, particularly those involved in AI and biotechnology, are expected to perform well. Investors should keep an eye on companies that are at the forefront of AI-driven healthcare solutions.7

Emergence of new investment opportunities

The Stargate project will likely create new investment opportunities in related industries, such as data center construction, cloud computing, and cybersecurity. Companies providing the infrastructure and security for AI technologies will be crucial to the project's success and could offer attractive investment prospects.8

Long-term growth potential

The healthcare sector's long-term growth potential is bolstered by the aging population and increasing demand for advanced medical treatments. The Stargate project's focus on AI-driven healthcare solutions aligns with these trends, making it a compelling investment opportunity for those with a long-term perspective.5

Policy and regulatory considerations

The project's success will depend on favorable policy and regulatory environments. Investors should stay informed about potential healthcare policy and regulation changes that could impact the sector. The current administration's support for AI and healthcare innovation is positive, but ongoing monitoring is essential.6

Final thoughts

The Stargate project represents a monumental step forward in the integration of AI and healthcare. By bringing together Oracle, OpenAI, and Softbank, this initiative aims to create a robust AI infrastructure that will drive advancements in cancer research and treatment. For healthcare investors, we believe the project offers a unique opportunity to capitalize on the transformative potential of AI in healthcare, promising to deliver significant benefits to patients and investors alike.

1 "Trump's AI deal fueling early cancer detection: Oracle's Larry Ellison." MSN News, January 2025. https://www.msn.com/en-us/technology/artificial-intelligence/trump-s-ai-deal-fueling-early-cancer-detection-oracle-s-larry-ellison/ar-AA1xIBQ8.
2 "Trump highlights partnership investing $500 billion in AI." AP News, January 2025. https://apnews.com/article/trump-ai-openai-oracle-softbank-son-altman-ellison-be261f8a8ee07a0623d4170397348c41.
3 "Trump announces largest AI infrastructure project 'in history' involving Softbank, OpenAI and Oracle." Fox Business, January 2025. https://www.foxbusiness.com/politics/trump-announces-major-ai-infrastructure-investment.
4 Leverage usually refers to a fund being exposed by more than 100% of its net asset value to assets or markets; typically resulting from the use of debt or derivatives. The use of leverage will also increase market exposure and magnify risk.
5 "Trump announces AI infrastructure investment backed by Oracle, OpenAI and Softbank." CNBC, January 2025. https://www.cnbc.com/2025/01/21/trump-ai-openai-oracle-softbank.html.
6 "Trump's AI deal fueling early cancer detection: Oracle's Larry Ellison." Fox Business, January 2025. https://www.foxbusiness.com/markets/trumps-ai-deal-fueling-early-cancer-detection-oracles-larry-ellison.
7 "6 Best Health Care ETFs to Buy for 2025." U.S. News & World Report, January 2025. https://money.usnews.com/investing/articles/best-health-care-etfs-to-buy-now.
8 "Announcing The Stargate Project." OpenAI, January 2025. https://openai.com/index/announcing-the-stargate-project/.

Important information

Closed-end funds are traded on the secondary market through one of the stock exchanges. The Fund's investment return and principal value will fluctuate so that an investor's shares may be worth more or less than the original cost. Shares of closed-end funds may trade above (a premium) or below (a discount) the net asset value (NAV) of the fund's portfolio. There is no assurance that the Fund will achieve its investment objective. Past performance does not guarantee future results.

Closed-end funds are similar to mutual funds in that they professionally manage portfolios of stocks, bonds or other investments. Unlike mutual funds, which continuously sell newly issued shares and redeem outstanding shares, most closed-end funds offer a fixed number of shares in an initial public offering (IPO) that are then traded on an exchange. Open-end funds can be bought or sold at the end of each trading day at their net asset values (NAVs). Because closed-end funds trade throughout the day on an exchange, the supply and demand for the shares determine their market price; closed-end funds'; market prices may fluctuate through the trading day and those prices may be higher or lower than their NAVs. Closed-end funds and mutual funds charge investors annual fees and expenses. All of these products may use leverage to enhance their returns, which can magnify a fund's gains as well as its losses. Closed-end funds typically do not have sales-based share classes with different commission rates and annual fees. Both vehicles seek to deliver returns based on their investment objectives, but neither is FDIC-insured. The Revenue Act of 1936 established guidelines for the taxation of funds, while the Investment Company Act of 1940 governs their structure. Aberdeen Standard Investments does not provide tax or legal advice; please consult your tax and/or legal advisor.

AA-040325-190157-1

Related articles

Insights5 min Read

Japan: Is the party over?

Amid moves to tighten policy, some investors are left wondering if it truly is time to turn off the music and evacuate Tokyo dancefloors. Find out why Alex Smith says, "Far from it."

Japan: Is the party over?
Insights3 min Read

Healthcare investing: Silver linings and cutting edges

Why we believe investing in healthcare – with an aging demographic and rapidly evolving landscape – can provide long-term tailwinds.

Healthcare investing: Silver linings and cutting edges
Insights4 min Read

Emerging markets: What Trump could mean for equities

A look at how President-elect Donald Trump’s return to office might impact emerging market equities.

Emerging markets: What Trump could mean for equities
Insights9 min Read

Are the tailwinds still in place for Japanese equities?

Despite summer volatility and short-term vulnerabilities, such as the yen carry trade and political uncertainties, why we believe the long-term outlook remains strong, allowing for a closer examination of Japan's market dynamics.

Are the tailwinds still in place for Japanese equities?
Insights3 min Read

Vietnam: A hot spot for growth

Exploring Vietnam's robust economic recovery and investment opportunities.

Vietnam: A hot spot for growth
View all articles
Contact us and support
Accessibility
Cookie policy
Legal and regulatory
Legal notice
Privacy
SecurityOpens in new window
FINRA Broker Check (open in a new window)Opens in new window
Copyright © Aberdeen Group plc 2025. All rights reserved.
Investors should carefully consider a fund’s investment objectives, risks, fees, charges, and expenses before investing any money. To obtain this and other fund information, please call 866-667-9231 to request a summary prospectus and/or prospectus, or download at www.abrdn.com/us. Please read the summary prospectus and/or prospectus carefully before investing any money.

Aberdeen Fund Distributors, LLC is a wholly owned subsidiary of abrdn Inc. abrdn Inc. is a wholly-owned subsidiary of abrdn plc. abrdn Funds are distributed by Aberdeen Fund Distributors LLC, Member FINRA and SIPC. 1900 Market Street, Suite 200, Philadelphia PA, 19103.

NOT FDIC INSURED | NO BANK GUARANTEE | MAY LOSE VALUE

For ETFs, please call 844-383-7289 or click here to access a prospectus online. Investing involves risk, including possible loss of principal. ETF shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund.

Important Risks

The abrdn Gold ETF Trust, abrdn Silver ETF Trust, abrdn Precious Metals Basket ETF Trust, abrdn Platinum ETF Trust and abrdn Palladium ETF Trust are not investment companies registered under the Investment Company Act of 1940 or a commodity pool for purposes of the Commodity Exchange Act. Shares of the Trusts are not subject to the same regulatory requirements as mutual funds. These investments are not suitable for all investors. Trusts focusing on a single commodity generally experience greater volatility.

Commodities generally are volatile and are not suitable for all investors. Trusts focusing on a single commodity generally experience greater volatility. Please refer to the prospectus for complete information regarding all risks associated with the Trusts. Shares in the Trusts are not FDIC insured and may lose value and have no bank guarantee.

The value of the Shares relates directly to the value of the precious metal held by the Trust and fluctuations in the price could materially adversely affect investment in the Shares. Several factors may affect the price of precious metals, including:

A change in economic conditions, such as a recession, can adversely affect the price of the precious metal held by the Trust. Some metals are used in a wide range of industrial applications, and an economic downturn could have a negative impact on its demand and, consequently, its price and the price of the Shares;

Investors’ expectations with respect to the rate of inflation;

Currency exchange rates;

Interest rates;

Investment and trading activities of hedge funds and commodity funds; and

Global or regional political, economic or financial events and situations. Should there be an increase in the level of hedge activity of the precious metal held by the trust or producing companies, it could cause a decline in world precious metal prices, adversely affecting the price of the Shares. Should there be an increase in the level of hedge activity of the precious metal held by the Trusts or producing companies, it could cause a decline in world precious metal prices, adversely affecting the price of the shares.

Also, should the speculative community take a negative view towards the precious metal held by the Trusts, it could cause a decline in prices, negatively impacting the price of the shares. There is a risk that part or all of the Trusts’ physical precious metal could be lost, damaged or stolen. Failure by the Custodian or Sub-Custodian to exercise due care in the safekeeping of the precious metal held by the Trusts could result in a loss to the Trusts.

The Trusts will not insure its precious metals and shareholders cannot be assured that the custodian will maintain adequate insurance or any insurance with respect to the precious metals held by the custodian on behalf of the Trust. Consequently, a loss may be suffered with respect to the Trust’s precious metal that is not covered by insurance.

Commodities generally are volatile and are not suitable for all investors.

Investors buy and sell shares on a secondary market (i.e., not directly from Trusts). Only market makers or "authorized participants" may trade directly with the Trusts, typically in blocks of 25k to 100k shares.

Commodities generally are volatile and are not suitable for all investors. This material must be accompanied or preceded by the prospectus. Carefully consider each Trust’s investment objectives, risk factors, and fees and expenses before investing. Please click here to review the prospectus.

ALPS Distributors, Inc. is the marketing agent for the abrdn Gold ETF Trust, abrdn Silver ETF Trust, abrdn Precious Metals Basket ETF Trust, abrdn Platinum ETF Trust and abrdn Palladium ETF Trust.

ALPS Distributors, Inc. is the distributor for abrdn ETFs.

ALPS Distributors, Inc. is not affiliated with the companies of Aberdeen.

'40 Act Fund Disclosure:

An investor should consider the investment objectives, risks, charges and expenses of the ETFs carefully before investing. To obtain a prospectus containing this and other important information, call 1-844-383-7289 or visit www.abrdn.com/us/etf. Read the prospectus carefully before investing.

Fund Risk: There are risks associated with investing including possible loss of principal. Commodities generally are volatile and are not suitable for all investors. There can be no assurance that the Fund’s investment objective will be met at any time. The commodities markets and the prices of various commodities may fluctuate widely based on a variety of factors. Because the Fund's performance is linked to the performance of highly volatile commodities, investors should consider purchasing shares of the Fund only as part of an overall diversified portfolio and should be willing to assume the risks of potentially significant fluctuations in the value of the Fund. Actively managed ETFs do not necessarily seek to replicate the performance of a specified index. Actively managed ETFs are subject to risks similar to stocks, including those related to short selling and margin maintenance. The Fund’s return may not match the return of the index.

Through holding of futures, options and options on futures contracts, the Fund may be exposed to (i) losses from margin deposits in the case of bankruptcy of the relevant broker, and (ii) a risk that the relevant position cannot be close out when required at its fundamental value. In pursuing its investment strategy, particularly when rolling futures contracts, the Fund may engage in frequent trading of its portfolio of securities, resulting in a high portfolio turnover rate.
As a "non-diversified" fund, the Fund may hold a smaller number of portfolio securities than many other funds. To the extent the Fund invests in a relatively small number of issuers, a decline in the market value of a particular security held by the Fund may affect its value more than if it invested in a larger number of issuers. The value of Shares may be more volatile than the values of shares of more diversified funds.

During situations where the cost of any futures contracts for delivery on dates further in the future is higher than those for delivery closer in time, the value of the Fund holding such contracts will decrease over time unless the spot price of that contract increases by the same rate as the rate of the variation in the price of the futures contract. The rate of variation could be quite significant and last for an indeterminate period of time, reducing the value of the Fund.

Changes in the laws of the United States and/or the Cayman Islands, under which the Fund and the Subsidiary are organized, respectively, could result in the inability of the Subsidiary to operate as intended and could negatively affect the Fund and its shareholders.

To the extent the Fund is exposed directly or indirectly to leverage (through investments in commodities futures contracts) the value of that Fund may be more volatile than if no leverage were present.

In order to qualify for the favorable U.S. federal income tax treatment accorded to a regulated investment company ("RIC"), the Fund must derive at least 90% of its gross income in each taxable year from certain categories of income ("qualifying income") and must satisfy certain asset diversification requirements. Certain of the Fund’s investments will not generate income that is qualifying income. The Fund intends to hold such commodity-related investments indirectly, through the Subsidiary. The Fund believes that income from the Subsidiary will be qualifying income because it expects that the Subsidiary will make annual distributions of its earnings and profits. [However, there can be no certainty in this regard, as the Fund has not sought or received an opinion of counsel confirming that the Subsidiary’s operations and resulting distributions would produce qualifying income for the Fund.] If the Fund were to fail to meet the qualifying income test or asset diversification requirements and fail to qualify as a RIC, it would be taxed in the same manner as an ordinary corporation, and distributions to its shareholders would not be deductible by the Fund in computing its taxable income. Investors buy and sell shares on a secondary market (i.e., not directly from the Trust). Only market makers or authorized participants may trade directly with the funds, typically in blocks of 25K to 100K shares.

The abrdn Bloomberg Industrial Metals K-1 Free ETF is new and has limited operating history.

“Bloomberg®” and “Bloomberg Commodity Index Total ReturnSM,” “Bloomberg Commodity Index 3 Month ForwardSM” and “Bloomberg Industrial Metals Subindex Total ReturnSM” are service marks of Bloomberg Finance L.P. and its affiliates, including Bloomberg Index Services Limited (“BISL”), the administrator of the indices (collectively, “Bloomberg”) and have been licensed for use for certain purposes by abrdn ETFs Advisors LLC. Bloomberg is not affiliated with abrdn ETFs Advisors LLC, and Bloomberg does not approve, endorse, review, or recommend abrdn Bloomberg All Commodity Strategy K-1 Free ETF (BCI), abrdn Bloomberg All Commodity Longer Dated Strategy K-1 Free ETF (BCD), and abrdn Bloomberg Industrial Metals K-1 Free ETF (BCIM). Bloomberg does not guarantee the timeliness, accurateness, or completeness of any data or information relating to Bloomberg Commodity Index Total Return, Bloomberg Commodity Index 3 Month Forward” and “Bloomberg Industrial Metals Subindex Total Return".

Please see the current prospectus, www.abrdn.com/us/etf for more information regarding the risk associated with an investment in the Funds.

S&P 500: The S&P 500 Index is the Standard & Poor’s composite index of 500 stocks, a widely recognized, unmanaged index of common stock prices.

Standard Deviation: Standard deviation is a statistical measure of the extent to which returns of an asset vary from its average.

Bloomberg Commodity Index: The Bloomberg Commodity Index (BCOM) is a broadly diversified commodity price index distributed by Bloomberg Indexes.

Discount- A situation when the share price of a fund trades below its net asset value.

Premium- A situation when the share price of a fund trades above its net asset value.

The Bloomberg Barclays US Aggregate Bond Index is a broad-based flagship benchmark that measures the investment grade, US dollar-denominated, fixed-rate taxable bond market.

Annualized Volatility is a statistical measure of the dispersion of returns for a given security or market index

Beta is a measure of the volatility, or systematic risk, of an individual stock in comparison to the unsystematic risk of the entire market

Sharpe ratio is the average return earned in excess of the risk-free rate per unit of volatility or total risk
NAV or Net Asset Value represents the per share/unit price of the fund on a specific date or time.

All material presented is compiled from sources believed to be reliable and current, but accuracy cannot be guaranteed. This is not to be construed as an offer to buy or sell any financial instruments. It is not our intention to state, indicate or imply in any manner that current or past results are indicative of future profitability or expectations. As with all investments there are associated inherent risks. Please obtain and review all financial material carefully before investing.

Aberdeen offers a variety of products and services intended solely for investors from certain countries or regions. Aberdeen does not offer these products or services outside their intended countries or regions. Your country of legal residence will determine the products or services that will be available to you. Nothing on this website should be considered a solicitation or offering for sale of any investment product or service to any person in any jurisdiction where such solicitation or offer would be unlawful.

Persons residing outside the United States are invited to visit our global website for more information about products and services available to non-U.S. investors.

Alternative investments involve specific risks that may be greater than those associated with traditional investments; are not suitable for all clients; and intended for experienced and sophisticated investors who meet specific suitability requirements and are willing to bear the high economic risks of the investment. Investments of this type may engage in speculative investment practices; carry additional risk of loss, including possibility of partial or total loss of invested capital, due to the nature and volatility of the underlying investments; and are generally considered to be illiquid due to restrictive repurchase procedures. These investments may also involve different regulatory and reporting requirements, complex tax structures, and delays in distributing important tax information.

Diversification does not ensure a profit or protect against a loss in a declining market.

Among the risks presented by private equity investing are substantial commitment requirements, credit risk, lack of liquidity, fees associated with investing, lack of control over investments and or governance, investment risks, leverage and tax considerations. Private equity investments can also be affected by environmental conditions / events, political and economic developments, taxes and other government regulations

Property investments may carry additional risk of loss due to the nature and volatility of the underlying investments and may not be available for investment by investors unless the investor meets certain regulatory requirements. In considering the prior performance information contained herein, potential investors should bear in mind that past performance is not necessarily indicative of future results, and there can be no assurance that such investments will achieve comparable results.


UNITED STATES RESIDENTS

The purpose of this website is to provide general information about the US-registered investment advisers which are part of Aberdeen, and the strategies they manage. The information provided is not intended as an offer or solicitation for the purchase or sale of any financial instrument.

Past performance is not indicative of future results, and there can be no guarantee as to the accuracy of market forecasts. Opinions, estimates, and forecasts may be changed without notice. This site does not provide financial or investment advice and does not take into account the particular financial circumstances of individual investors. Before investing, investors should seek their own professional advice. The views and opinions expressed are provided for general information only, and do not constitute specific tax, legal, or investment advice to, or recommendations for, any person. We suggest that you consult your financial or tax advisor, accountant, or attorney with regard to your specific situation.

In the United States, Aberdeen is the marketing name for the following affiliated, registered investment advisers: abrdn Inc., abrdn Investments Limited, and abrdn Asia Limited.


Privacy and Cookies Policy

The attention of users is drawn to Aberdeen’s Privacy and Cookies Policy which includes details on the use of performance, identification and targeting cookies (both our own and third parties) to enhance the functionality of the web-site, to enable the Group to monitor usage and to assist with future communications. By continuing to use this site users will be deemed to have accepted this policy and the use of cookies for these limited purposes only.


Business Continuity Management & Disaster Recovery Programs

Copyright

Copyright of this material is owned by Aberdeen. It may be printed or downloaded for personal use only. Aberdeen expressly prohibits the dissemination, reproduction or transmission of any of the contents of this site in any form, other than for personal use.

The information contained in this website does not constitute an offer of, or an invitation to apply for securities in any jurisdiction where such an offer or invitation is unlawful, or in which the person making such an offer is not qualified to do so.

As a convenience to our users, some of the documents on this website may contain links to information created and maintained by other, unaffiliated organizations. Aberdeen does not control, cannot guarantee, and is not responsible for the accuracy, timeliness, or even the continued availability or existence of this outside information.

There are important legal and regulatory restrictions which you were advised to read before proceeding. By reviewing this information, you are representing that you have understood and accepted the restrictions and terms herein.